Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Direct Biologics, Dr. Reddy’s Laboratories, Edesa, Eisai, Enlivex, Gilead Sciences, Immunitybio, Moderna, Prestige, Recce, Sorrento, Tevogen.